Technology & AI

Isomorphic Labs secures $5 billion in new funding round

Isomorphic Labs, an AI drug discovery company led by Sir Demis Hassabis, has raised $5 billion in a Series C round.

By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .

This story is no longer being updated. It reflects reporting up to .

What happened

Isomorphic Labs, an AI drug discovery company led by Sir Demis Hassabis, has raised $5 billion in a Series C round. The funding comes just six months after a $2.1 billion round. The company plans to use the money to move its drug pipeline toward clinical trials.

Why it matters

The company has no approved drugs yet, so the funding is meant to push its pipeline forward. The reports describe the round as a record for AI in biology.

Coverage

More from Technology & AI

All Technology & AI news · Technology & AI story archive